13,14-dihydro-15-keto-tetranor Prostaglandin F1α (Synonyms: 5β, 7αdihydroxy11ketotetranorProstanoic Acid, 9β13,14dihydro15ketotetranor Prostaglandin F1α, 9β,11αdihydroxy15oxo2,3,4,5tetranorProstanoic Acid) |
Catalog No.GC41903 |
The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 24379-94-0
Sample solution is provided at 25 µL, 10mM.
The metabolism of F series prostaglandins (PGs), including PGF1α and PGF2α, commonly begins with the reduction of the double bond between C-13 and C-14 and oxidation of the hydroxyl group at C-15, producing 13,14-dihydro-15-keto PGs. The removal of four carbons at the α-terminus and oxidation of the terminal ω carbon produces the abundant urinary metabolites, including tetranor-PGFM. 13,14-dihydro-15-keto tetranor PGF1α is a potential metabolite of either PGF1α or PGF2α and likely precursor to tetranor-PGFM.
Average Rating: 5
(Based on Reviews and 22 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *